Decision Resources announced today the availability of a new DR Report entitled The Hematology Market: An Overview of Marketed and Emerging Therapies. The report reviews various blood disorders and the current and emerging therapies used to treat these disorders. The study finds that pharmaceutical companies are increasingly turning their attention to the hematology market for its significant growth potential.

(Photo: http://www.newscom.com/cgi-bin/prnh/20000303/DECISION )

Hematological disorders constitute significant growth potential for the pharmaceutical industry, and the high amount of developmental effort and industry spending in this segment is commensurate with this potential. Because the functions of blood are many and complex, several disorders, both benign (non-cancerous) and malignant (cancerous), can develop. As such, hematology is an important component of cardiovascular medicine, immunology, and oncology. Available therapies for the blood-clotting disorders include a range of anticoagulant agents, thrombolytic agents, and coagulation-inducing factors.

"Market growth in the various categories of hematology disorders varies, but potential is everywhere. Anticoagulants, for example, could experience compound sales growth of 50% or more through 2010." said Tracy DeGregorio, Director, Decision Resources.

  The study also includes in-depth analysis on the following disorders:   -- Thrombosis -- which develops when thrombocytes that work to patch up a      vessel injury form clots that obstruct veins or arteries. The      obstruction produced can disrupt normal blood flow and lead to heart      attack, stroke, or lack of oxygen delivery to other organs.   -- Hemophilias -- which are genetic disorders associated with the      inability to form blood clots normally and quickly.   -- Anemia -- which are acquired or hereditary abnormalities resulting in      the diminished ability of erythrocytes to provide adequate oxygen to      the body.   -- Leukemias and lymphomas -- which are cancerous conditions affecting the      immature blood-forming cells of the bone marrow.  

About Blood Blood has three entirely distinct functions (transport of gases and nutrients, sealing of wounds, and immunological defense). As blood circulates through the heart, arteries, veins, and capillaries, it brings with it nourishment, oxygen, electrolytes, hormones, vitamins, antibodies, and heat, and it carries away metabolic waste and carbon dioxide. Blood also fights against infection and helps heal wounds. Blood accounts for approximately 7% of the body's weight and is regenerated so easily that any healthy human is able to donate more than 5% of his or her total volume every month.

About DR Reports

DR Reports are research publications that explore development activity, ground-breaking advances, and emerging trends in health care markets. DR Reports are created by engaging experts in the field, conducting extensive secondary research, and synthesizing the findings into a cohesive, well- documented written analysis.

About Decision Resources

Decision Resources, Inc. is a world leader in research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets. The Company has provided strategic information services for 25 years, assessing international pharmaceutical and health care industry trends. Visit Decision Resources at http://www.dresources.com/.

All company brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

   CONTACT:    Elizabeth Marshall    Decision Resources    781-296-2563    emarshall@dresources.com 

MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X36534859

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20000303/DECISION

AP Archive: http://photoarchive.ap.org/

PRN Photo Desk, 888-776-6555 or 212-782-2840

SOURCE: Decision Resources, Inc.

CONTACT: Elizabeth Marshall of Decision Resources, +1-781-296-2563,
emarshall@dresources.com

Decision Resources Publishes New Report on Novel Anticoagulants

View Now